Related references
Note: Only part of the references are listed.Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells
Xing-Jie Liang et al.
CANCER RESEARCH (2008)
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1
Queenie W. -L. Wong et al.
GASTROENTEROLOGY (2008)
Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis
Tanja Nussbaum et al.
HEPATOLOGY (2008)
Proliferation versus migration in platelet-derived growth factor signaling -: The key role of endocytosis
Alina De Donatis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential
Barbara Belletti et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein
Lawrence R. Benjamin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis
Ramdzan M. Zubaidah et al.
PROTEOMICS (2008)
Protumorigenic overexpression of Stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis
Stephan Singer et al.
HEPATOLOGY (2007)
Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin
Yangchao Chen et al.
HEPATOLOGY (2007)
FBPs are calibrated molecular tools to adjust gene expression
Hye-Jung Chung et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma
R-H Yuan et al.
JOURNAL OF PATHOLOGY (2006)
Dysregulation of growth factor signaling in human hepatocellular carcinoma
K. Breuhahn et al.
ONCOGENE (2006)
Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury
S Barone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression
A Weber et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
AU-rich elements in the collagenase 3 mRNA mediate stabilization of the transcript by cortisol in osteoblasts
S Rydziel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter
JR Huth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression
K Breuhahn et al.
CANCER RESEARCH (2004)
A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery
R Gherzi et al.
MOLECULAR CELL (2004)
Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes
W Prange et al.
JOURNAL OF PATHOLOGY (2003)
Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation
MJ Kim et al.
NATURE GENETICS (2003)
A homolog of FBP2/KSRP binds to localized mRNAs in Xenopus oocytes
TT Kroll et al.
DEVELOPMENT (2002)
Structure and dynamics of KH domains from FBP bound to single-stranded DNA
DT Braddock et al.
NATURE (2002)
Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin/Op18
SSL Andersen
TRENDS IN CELL BIOLOGY (2000)
Share Paper
